Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • brentp
    Member
    • Apr 2010
    • 72

    #1

    bs-seq in colorspace

    there is some discussion of this in another thread.

    i'm considering doing the following for bs-treated reads in colorspace:

    + convert C to T in reference (and for reverse-complement of reference)
    + for reads:
    - convert to nucleotide space
    - convert C to T
    - convert back to colorspace

    + use aligner (bowtie/bfast) to do mappings
    + ... do usual stuff to calculate per-base methylation


    what's wrong with this approach? or how could it be improved for colorspace? is this valid with a subset of reads, so that i could align some this way and then use, for example SOCS (which is very computationally intensive) for unmapped reads?

    thanks for any ideas.
  • mrawlins
    Member
    • Apr 2010
    • 63

    #2
    Converting to nucleotide space is generally a bad idea. Converting back will sometimes alleviate this problem, but I don't think that's true in this case.

    A single mismatch in colorspace will change the identifications for all subsequent positions. That will mean:
    1) some bases that were C were not called correctly, so not changed to T. The colorspace representation doesn't change even though it should.
    2) some bases that weren't C were incorrectly called as C, so they were changed to T. The colorspace representation changes even though it shouldn't.

    It might be possible to find color transitions that imply a base is C and change those to the corresponding transition for base T, but I think that would miss a few cases, and hence a lot of reads.

    I could be wrong on my assessment here, but it seems like it would produce quite a few false positives and false negatives. I don't have any better ideas, though.

    It seems that the new ECC stuff from ABI would alleviate a lot of this issue, as it allows trivial conversion to base-space. That assumes, though, that you haven't run the samples yet and have available either the equipment or a collaborator/service that has the latest equipment, as it doesn't work on SOLiD 4 or older.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 10:13 AM
    0 responses
    13 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Working...